Homology Medicines Inc. (FIXX)
NASDAQ: FIXX
· Real-Time Price · USD
0.93
0.00 (0.26%)
At close: Mar 25, 2024, 9:00 PM
Homology Medicines Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -28.14M | -33.23M | -66.5M | -83.09M | -112.96M | -131.14M | -131.91M | -125.95M | -5M | -4.29M | -1.18M | -2.59M | -95.76M | -91.97M | -89.6M | -94.44M |
Depreciation & Amortization | -220K | -268K | 60K | 382K | 578K | 874K | 1.06M | 1.17M | 1.29M | 3.07M | 4.85M | 6.62M | 8.35M | 8.34M | 8.25M | 7.92M |
Stock-Based Compensation | 5.05M | 4.55M | 4.84M | 5.37M | 7.32M | 9.57M | 10.63M | 11.37M | 13.05M | 14.63M | 16.08M | 17.41M | 17.25M | 16.15M | 15.27M | 14.25M |
Other Working Capital | 15.23M | 8.25M | -1.28M | -4.74M | -9.3M | 4.41M | 8.6M | 4.24M | 4.33M | -5.3M | -7.76M | -8.72M | -39.32M | -26.97M | -29.24M | -25.81M |
Other Non-Cash Items | -44.54M | -39.3M | -17.21M | 5.97M | 8.24M | 3.66M | 5.01M | 6.34M | -126.35M | -126.7M | -128.11M | -129.51M | 1.19M | 1.12M | 1.06M | 1.2M |
Deferred Income Tax | 12.93M | 5.13M | 2.67M | n/a | n/a | 7.8M | 5.13M | n/a | n/a | 357K | 607K | 859K | 1.03M | 1.56M | 1.3M | 1.05M |
Change in Working Capital | 19.95M | 8.41M | 3.13M | -5.14M | -7.21M | 7.38M | 8.23M | -1.96M | 3.35M | -3.96M | -9.6M | -3.41M | -41.8M | -26.12M | -30.71M | -28.29M |
Operating Cash Flow | -53.84M | -62.94M | -81.23M | -84.73M | -96.23M | -101.85M | -101.84M | -109.03M | -113.66M | -116.89M | -117.35M | -110.61M | -109.75M | -90.93M | -94.43M | -98.31M |
Capital Expenditures | -486K | -148K | -411K | n/a | -228K | -575K | -243K | -364K | -1.28M | -1.61M | -2.08M | -2.73M | -2.4M | -3.01M | -2.69M | -2.52M |
Cash Acquisitions | -770K | -554K | 338K | 554K | -31.05M | -161.26M | -161.6M | -161.6M | n/a | 130M | 130M | 130M | n/a | n/a | n/a | n/a |
Purchase of Investments | 47.96M | 47.96M | -47.96M | -47.96M | -73.24M | -73.24M | -133.49M | -182.74M | -287.46M | -287.46M | -179.25M | -142.97M | -97.39M | -97.33M | -97.33M | -104.34M |
Sales Maturities Of Investments | -47.95M | -16.45M | 44.86M | 117.45M | 174.24M | 160.74M | 135.88M | 82.88M | 65.46M | 91.46M | 96.46M | 88.46M | 49M | 5M | 39M | 111.59M |
Other Investing Acitivies | 338K | -31.05M | -30.71M | 29.95M | 61.55M | 222.94M | 114.39M | 12.14M | 110.54M | -19.46M | 88.75M | 130M | n/a | -64.52K | -64.52K | -64.52K |
Investing Cash Flow | -914K | 30.8M | -2.84M | 70.05M | 101.33M | 87.6M | 2.15M | -100.22M | 36.72M | 62.39M | 175.13M | 202.76M | -50.79M | -95.4M | -61.08M | 4.66M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 90.61M | 90.63M | 94.85M | 99.38M | 184K | 202K | 308K | 306K | 596K | 565K | 820K | 50.57M | 52.17M | 104.16M | 104.19M | 54.69M |
Financial Cash Flow | 90.57M | 90.58M | 94.84M | 99.38M | 184K | 202K | 308K | 306K | 596K | 565K | 820K | 50.57M | 52.17M | 104.16M | 104.19M | 54.69M |
Net Cash Flow | 8.44M | 31.07M | 20.93M | 84.7M | 5.28M | -14.05M | -99.39M | -208.95M | -76.35M | -53.94M | 58.6M | 142.71M | -108.37M | -82.17M | -51.32M | -38.96M |
Free Cash Flow | -54.33M | -63.08M | -81.64M | -84.73M | -96.46M | -102.43M | -102.09M | -109.39M | -114.95M | -118.51M | -119.43M | -113.34M | -112.15M | -93.95M | -97.13M | -100.83M |